Evaluation of Effectiveness of the Unplugged Program on Gambling Among Adolescents (GAPUnplugged)

NCT05630157 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3046

Last updated 2022-11-29

No results posted yet for this study

Summary

The main aim of this study is to assess the effectiveness of a new component on gambling prevention to be added to the evidence-based school based prevention curriculum "Unplugged". The evaluation of effectiveness will be performed by conducting a non-randomized cluster controlled trial in classes of pupils 12 to 14 years old. Classes will be allocated to the intervention arm (receving Unplugged + the gambling component) or to the control arm (usual curriculum, no specific intervention).

The intervention includes 12 prevention units and a 13th unit focused on gambling. It will be carried out by Unplugged teachers trained in a specific training course. Data collection will take place before and after the intervention through a standardized questionnaire developed ad hoc and containing previously validated questions.

Conditions

  • Gambling

Interventions

BEHAVIORAL

Unplugged plus gambling component

12 units/lessons of the Unplugged prevention curriculum plus a gambling component including specific gambling contents in units 3-4-5-7-9 and a 13th unit based on probability and mathematical concepts taught through an online simulator

Sponsors & Collaborators

  • ASL Roma 1

    collaborator UNKNOWN
  • Università degli Studi del Piemonte Orientale Amedeo Avogadro

    lead OTHER

Principal Investigators

  • Federica D Vigna-Taglianti, PhD · University of Eastern Piedmont

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
14 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-11-21
Primary Completion
2023-11-21
Completion
2023-12-31

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05630157 on ClinicalTrials.gov